Roisin M Connolly

18PUBLICATIONS
140CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 11, 2026
Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

|Jun 30, 2025
Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with entinostat + nivolumab + ipilimumab.

Evanthia Roussos Torres, Ludmila Danilova, Jospeh Tandurella

|Apr 03, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.

Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter

|Dec 09, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck, Eva Ciruelos, Guy Jerusalem

|Sep 13, 2024
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck, Eva Ciruelos, Guy Jerusalem

|Jun 21, 2024
Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.

David O'Reilly, Abdul Rehman Farooq, Paul Nevins Selvadurai

Pageof 3

Frequent Collaborators

5 joint publications

Vered Stearns

4 joint publications

Antonio C Wolff

4 joint publications

Evanthia T Roussos Torres

3 joint publications

Seamus O'Reilly